APC c.1480_1481delinsCC ;(p.S494P)

Variant ID: 5-112162876-AG-CC

NM_000038.5(APC):c.1480_1481delinsCC;(p.S494P)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity.

Cell Discovery
Long, Yiru Y; Sun, Jianhua J; Song, Tian-Zhang TZ; Liu, Tingting T; Tang, Feng F; Zhang, Xinxin X; Ding, Longfei L; Miao, Yunqiu Y; Zhu, Weiliang W; Pan, Xiaoyan X; An, Qi Q; Qin, Mian M; Tong, Xiankun X; Peng, Xionghua X; Yu, Pan P; Zhu, Peng P; Xu, Jianqing J; Zhang, Xiaoyan X; Zhang, Yachun Y; Liu, Datao D; Chen, Ben B; Chen, Huilin H; Zhang, Leike L; Xiao, Gengfu G; Zuo, Jianping J; Tang, Wei W; Zhou, Ji J; Li, Heng H; Xu, Zhijian Z; Zheng, Hong-Yi HY; Long, Xin-Yan XY; Qin, Qiuping Q; Gan, Yong Y; Ren, Jin J; Huang, Wei W; Zheng, Yong-Tang YT; Jin, Guangyi G; Gong, Likun L
Publication Date: 2022-02-01

Variant appearance in text: APC: S494P
PubMed Link: 35102138
Variant Present in the following documents:
  • Main text
  • 41421_2021_Article_370.pdf
View BVdb publication page



Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.

Cell Host & Microbe
Vanshylla, Kanika K; Fan, Chengcheng C; Wunsch, Marie M; Poopalasingam, Nareshkumar N; Meijers, Matthijs M; Kreer, Christoph C; Kleipass, Franziska F; Ruchnewitz, Denis D; Ercanoglu, Meryem S MS; Gruell, Henning H; Münn, Friederike F; Pohl, Kai K; Janicki, Hanna H; Nolden, Tobias T; Bartl, Simone S; Stein, Saskia C SC; Augustin, Max M; Dewald, Felix F; Gieselmann, Lutz L; Schommers, Philipp P; Schulz, Thomas F TF; Sander, Leif Erik LE; Koch, Manuel M; Łuksza, Marta M; Lässig, Michael M; Bjorkman, Pamela J PJ; Klein, Florian F
Publication Date: 2021-12-18

Variant appearance in text: APC: S494P
PubMed Link: 34973165
Variant Present in the following documents:
  • Main text
  • mmc2.pdf
  • main.pdf
View BVdb publication page



Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.

Cell Host & Microbe
Vanshylla, Kanika K; Fan, Chengcheng C; Wunsch, Marie M; Poopalasingam, Nareshkumar N; Meijers, Matthijs M; Kreer, Christoph C; Kleipass, Franziska F; Ruchnewitz, Denis D; Ercanoglu, Meryem S MS; Gruell, Henning H; Münn, Friederike F; Pohl, Kai K; Janicki, Hanna H; Nolden, Tobias T; Bartl, Simone S; Stein, Saskia C SC; Augustin, Max M; Dewald, Felix F; Gieselmann, Lutz L; Schommers, Philipp P; Schulz, Thomas F TF; Sander, Leif Erik LE; Koch, Manuel M; Łuksza, Marta M; Lässig, Michael M; Bjorkman, Pamela J PJ; Klein, Florian F
Publication Date: 2022-01-12

Variant appearance in text: APC: S494P
PubMed Link: 34973165
Variant Present in the following documents:
  • Main text
  • mmc2.pdf
  • main.pdf
View BVdb publication page



Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants.

Expert Review Of Vaccines
Chatterjee, Bhaswati B; Thakur, Suman S SS
Publication Date: 2021-10-26

Variant appearance in text: APC: S494P
PubMed Link: 34697980
Variant Present in the following documents:
  • Main text
View BVdb publication page